SOCMA Gives Evidence on Safety of Imported Medicines

The Synthetic Organic Chemical Manufacturer's Association (SOCMA) has been called to testify at a congressional hearing on November 1 about the safety of drugs imported into the U.S. Representatives of SOCMA's Bulk Pharmaceutical Task Force (BPTF) will testify before the House of Energy and Commerce Sub-committee on Oversight and Investigations. The title of the hearing is ‘FDA Foreign Inspection Program: A System at Risk.’ The BPTF will inform the committee about a lack of government inspections of overseas facilities manufacturing active pharma...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers